Diffusion-weighted magnetic resonance imaging of the pancreas: Diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis

Investigative Radiology

Volumn 49, Issue 2, 2014, Pages 93-100

  Concia, Massimo ^a   Sprinkart, Alois M ^a,b   Penner, Arndt Hendrik ^a   Brossart, Peter ^a   Gieseke, Jürgen ^a,c   Schild, Hans H ^a   Willinek, Winfried A ^a   Mürtz, Petra ^a  

^a UNIVERSITY OF BONN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Diffusion; IVIM; MRI; Pancreas diagnostics; Perfusion

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; HUMAN; INFORMED CONSENT; INTRAVOXEL INCOHERENT MOTION MODEL; MALE; MICROCIRCULATION; MIDDLE AGED; NONBIOLOGICAL MODEL; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS ADENOCARCINOMA; PANCREAS DISEASE; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY GATED IMAGING; RETROSPECTIVE STUDY; SIGNAL NOISE RATIO; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTION; MOVEMENT; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PANCREATITIS; REPRODUCIBILITY OF RESULTS; RESPIRATORY-GATED IMAGING TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84893637962     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182a71cc3     Document Type: Article

References (51)

1. Nanashima A, Tobinaga S, Abo T, et al. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Hepatogastroenterology. 2012;59:911-915.
2. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102-125.
3. Ichikawa T, Erturk SM, Motosugi U, et al. High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 2007;188:409-414.
4. Matsuki M, Inada Y, Nakai G, et al. Diffusion-weighed MR imaging of pancreatic carcinoma. Abdom Imaging. 2007;32:481-483.
5. Takeuchi M, Matsuzaki K, Kubo H, et al. High-b-value diffusion-weighted magnetic resonance imaging of pancreatic cancer and mass-forming chronic pancreatitis: preliminary results. Acta Radiol. 2008;49:383-386.
6. Muraoka N, Uematsu H, Kimura H, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging. 2008;27:1302-1308.
7. Fattahi R, Balci NC, Perman WH, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 2009;29:350-356.
8. Fukukura Y, Takumi K, Kamimura K, et al. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings. Radiology. 2012;263: 732-740.
9. Brenner R, Metens T, Bali M, et al. Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection. Eur J Radiol. 2012;81:e746-e749.
10. Thomas S, Kayhan A, Lakadamyali H, et al. Diffusion MRI of acute pancreatitis and comparison with normal individuals using ADC values. Emerg Radiol. 2012;19:5-9.
11. Yoshikawa T, Ohno Y, Kawamitsu H, et al. Abdominal apparent diffusion coefficient measurements: effect of diffusion-weighted image quality and usefulness of anisotropic images. Magn Reson Imaging. 2008;26:1415-1420.
12. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497-505.
13. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.
14. Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol. 2011;196:1351-1361.
15. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology. 2008;249:748-752.
16. Yamada I, Aung W, Himeno Y, et al. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology. 1999;210:617-623.
17. Lemke A, Laun FB, Klauss M, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol. 2009;44:769-775.
18. Klauss M, Lemke A, Grunberg K, et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol. 2011;46:57-63.
19. Re TJ, Lemke A, Klauss M, et al. Enhancing pancreatic adenocarcinoma delineation in diffusion derived intravoxel incoherent motion f-maps through automatic vessel and duct segmentation. Magn Reson Med. 2011;66:1327-1332.
20. Lee SS, Byun JH, Park BJ, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging. 2008;28:928-936.
21. Klauss M, Gaida MM, Lemke A, et al. Fibrosis and pancreatic lesions: counterintuitive behavior of the diffusion imaging-derived structural diffusion coefficient D. Invest Radiol. 2013;48:129-133.
22. Lemke A, Stieltjes B, Schad LR, et al. Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging. 2011;29:766-776.
23. Cho GY, Kim S, Jensen JH, et al. A versatile flow phantom for intravoxel incoherent motion MRI. Magn Reson Med. 2012;67:1710-1720.
24. Yao XZ, Yun H, Zeng MS, et al. Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T. Magn Reson Imaging. 2012;31:524-528.
25. Momtahen AJ, Balci NC, Alkaade S, et al. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI. Acta Radiol. 2008;49:490-497.
26. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol. 2006;187:1521-1530.
27. Dale BM, Braithwaite AC, Boll DT, et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusionweighted imaging of the abdomen. Invest Radiol. 2010;45:104-108.
28. Wiggermann P, Grutzmann R, Weissenbock A, et al. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and massforming focal pancreatitis. Acta Radiol. 2012;53:135-139.
29. Muhi A, Ichikawa T, Motosugi U, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusionweighted imaging findings. J Magn Reson Imaging. 2012;35:827-836.
30. Schoennagel BP, Habermann CR, Roesch M, et al. Diffusion-weighted imaging of the healthy pancreas: apparent diffusion coefficient values of the normal head, body, and tail calculated from different sets of b-values. J Magn Reson Imaging. 2011;34:861-865.
31. Herrmann J, Schoennagel BP, Roesch M, et al. Diffusion-weighted imaging of the healthy pancreas: ADC values are age and gender dependent. J Magn Reson Imaging. 2013;37:886-891.
32. Wang Y, Chen ZE, Yaghmai V, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging. 2011;33:1071-1079.
33. Akisik MF, Aisen AM, Sandrasegaran K, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250:103-109.
34. Balci NC, Perman WH, Saglam S, et al. Diffusion-weighted magnetic resonance imaging of the pancreas. Top Magn Reson Imaging. 2009;20:43-47.
35. Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005;53:1432-1440.
36. Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med. 1992;27:171-178.
37. Duong TQ, Kim SG. In vivo MR measurements of regional arterial and venous blood volume fractions in intact rat brain. Magn Reson Med. 2000;43:393-402.
38. Lewin M, Fartoux L, Vignaud A, et al. The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol. 2011;21:281-290.
39. Schmidt J, Ryschich E, Daniel V, et al. Vascular structure and microcirculation of experimental pancreatic carcinoma in rats. Eur J Surg. 2000;166:328-335.
40. Chu GC, Kimmelman AC, Hezel AF, et al. Stromal biology of pancreatic cancer. J Cell Biochem. 2007;101:887-907.
41. Neesse A, Michl P, Frese KK, et al. Stromal biology and therapy in pancreatic cancer. Gut. 2011;60:861-868.
42. Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457-1461.
43. Delrue L, Blanckaert P, Mertens D, et al. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography. Abdom Imaging. 2012;37:595-601.
44. Hocke M, Dietrich CF. Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound. Int J Inflam. 2012;2012:420787.
45. Ueda T, Oda T, Kinoshita T, et al. Neovascularization in pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol Rep. 2002;9:239-245.
46. Lemke A, Laun FB, Simon D, et al. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med. 2010;64:1580-1585.
47. Stark DD, Moss AA, Goldberg HI, et al. Magnetic resonance and CT of the normal and diseased pancreas: a comparative study. Radiology. 1984;150: 153-162.
48. Xing D, Papadakis NG, Huang CL, et al. Optimised diffusion-weighting for measurement of apparent diffusion coefficient (ADC) in human brain. Magn Reson Imaging. 1997;15:771-784.
49. Kartalis N, Loizou L, Edsborg N, et al. Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratorytriggered, free-breathing and breath-hold techniques. Eur Radiol. 2012;22: 2186-2192.
50. Mü rtz P, Flacke S, Träber F, et al. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology. 2002;224:258-264.
51. Andreou A, Koh DM, Collins DJ, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol. 2013;23:428-434.